Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study.
暂无分享，去创建一个
M. Hughes | R. Schooley | R. Gross | J. Mellors | A. Collier | J. Ritz | B. Grinsztejn | C. Godfrey | P. Mugyenyi | L. Mohapi | V. Mave | N. Kumarasamy | E. Hogg | C. Wallis | A. Avihingsanon | B. Santos | R. Salata | S. W. Cardoso | C. Kanyama | R. Secours | S. Faesen | Wadzanai P Samaneka | R. Mngqibisa | P. Sugandhavesa | Linda Wieclaw | Aggrey Bukuru | Mumbi Makanga | Beatrice Wangari Ndege | Sandy Nerette Fontain | M. Van Schalkwyk | Javier Valencia | E. Montalbán | J. Valencia